Anastrozole-induced carpal tunnel syndrome: Results from the international breast cancer intervention study II prevention trial

Journal of Clinical Oncology

Volumn 34, Issue 2, 2016, Pages 139-143

  Spagnolo, Francesco ^a   Sestak, Ivana ^a   Howell, Anthony ^b   Forbes, John F ^c   Cuzick, Jack ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; CORTICOSTEROID; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; AROMATASE INHIBITOR; NITRILE; TRIAZOLE DERIVATIVE;

ADULT; ARTICLE; BODY MASS; BREAST CANCER; CANCER PATIENT; CARPAL TUNNEL SYNDROME; CONTROLLED CLINICAL TRIAL (TOPIC); DISEASE SEVERITY; DRUG WITHDRAWAL; EXPLORATORY RESEARCH; FEMALE; HIGH RISK PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MULTICENTER STUDY (TOPIC); MUSCULOSKELETAL DISEASE; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; AGED; BREAST NEOPLASMS; CHEMICALLY INDUCED; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; INTERNATIONAL COOPERATION; MIDDLE AGED; MULTICENTER STUDY; ODDS RATIO; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; AROMATASE INHIBITORS; BREAST NEOPLASMS; CARPAL TUNNEL SYNDROME; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INCIDENCE; INTERNATIONAL COOPERATION; MIDDLE AGED; NITRILES; ODDS RATIO; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TRIAZOLES;

EID: 84954231520     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2015.63.4972     Document Type: Article

References (31)

1. Chammas M: Carpal tunnel syndrome. Chir Main 33:75-94, 2014
2. Palumbo CF, Szabo RM: Examination of patients for carpal tunnel syndrome sensibility, provocative, and motor testing. Hand Clin 18:269-277, vi, 2002
3. Graham B: The value added by electrodiagnostic testing in the diagnosis of carpal tunnel syndrome. J Bone Joint Surg Am 90:2587-2593, 2008
4. Kaplan Y, Kurt SG, Karaer H: Carpal tunnel syndrome in postmenopausal women. J Neurol Sci 270:77-81, 2008
5. Ferry S, Hannaford P, Warskyj M, et al: Carpal tunnel syndrome: A nested case-control study of risk factors in women. Am J Epidemiol 151:566-574, 2000
6. Finsen V, Zeitlmann H: Carpal tunnel syndrome during pregnancy. Scand J Plast Reconstr Surg Hand Surg 40:41-45, 2006
7. Pascual E, Giner V, Aróstegui A, et al: Higher incidence of carpal tunnel syndrome in oophorectomized women. Br J Rheumatol 30:60-62, 1991
8. Geoghegan JM, Clark DI, Bainbridge LC, et al: Risk factors in carpal tunnel syndrome. J Hand Surg [Br] 29:315-320, 2004
9. Confino-Cohen R, Lishner M, Savin H, et al: Response of carpal tunnel syndrome to hormone replacement therapy. BMJ 303:1514, 1991
10. Hall GM, Spector TD, Studd JW: Carpal tunnel syndrome and hormone replacement therapy. BMJ 304:382, 1992
11. Sestak I, Sapunar F, Cuzick J: Aromatase inhibitor-induced carpal tunnel syndrome: Results from the ATAC trial. J Clin Oncol 27:4961-4965, 2009
12. Mieog JSD, Morden JP, Bliss JM, et al: IES Steering Committee: Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2-3 years of tamoxifen: A retrospective analysis of the Intergroup Exemestane Study. Lancet Oncol 13:420-432, 2012
13. Colleoni M, Giobbie-Hurder A, Regan MM, et al: Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 study. J Clin Oncol 29:1117-1124, 2011
14. Dowsett M, Cuzick J, Ingle J, et al: Metaanalysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen. J Clin Oncol 28:509-518, 2010
15. Cuzick J, Sestak I, Forbes JF, et al: IBIS-II investigators: Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): An international, double-blind, randomised placebocontrolled trial. Lancet 383:1041-1048, 2014
16. Goss PE, Ingle JN, Alés-Martínez JE, et al: NCIC CTG MAP.3 Study Investigators: Exemestane for breast-cancer prevention in postmenopausal women. N Engl J Med 364:2381-2391, 2011
17. Sestak I, Cuzick J, Sapunar F, et al: ATAC Trialists' Group: Risk factors for joint symptoms in patients enrolled in the ATAC trial: A retrospective, exploratory analysis. Lancet Oncol 9:866-872, 2008
18. Coombes RC, Hall E, Gibson LJ, et al: Intergroup Exemestane Study: A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 350:1081-1092, 2004
19. Partridge AH, La Fountain A, Mayer E, et al: Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. J Clin Oncol 26:556-562, 2008
20. Henry NL, Azzouz F, Desta Z, et al: Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancer. J Clin Oncol 30:936-942, 2012
21. O'Connor D, Marshall SC, Massy-Westropp N, et al: Non-surgical treatment (other than steroid injection) for carpal tunnel. Cochrane Database Syst Rev CD003219, 2003
22. Padua L, Padua R, Aprile I, et al: Italian CTS Study Group. Carpal tunnel syndrome: Multiperspective follow-up of untreated carpal tunnel syndrome: a multicenter study. Neurology 56:1459-1466, 2001
23. Llombart-Cussac A, Ruiz A, Antón A, et al: Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: Final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial. Cancer 118: 241-247, 2012
24. Goss PE, Ingle JN, Pritchard KI, et al: Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27-a randomized controlled phase III trial. J Clin Oncol 31: 1398-1404, 2013
25. Morales L, Pans S, Paridaens R, et al: Debilitating musculoskeletal pain and stiffness with letrozole and exemestane: Associated tenosynovial changes on magnetic resonance imaging. Breast Cancer Res Treat 104:87-91, 2007
26. Dizdar O, Ozçakar L, Malas FÜ, et al: Sonographic and electrodiagnostic evaluations in patients with aromatase inhibitor-related arthralgia. J Clin Oncol 27:4955-4960, 2009
27. Lintermans A, Neven P: Pharmacology of arthralgia with estrogen deprivation. 10th Int Aromatase Conf Proc Sept 2010 76:781-785, 2011
28. Blomqvist A: Sex hormones and pain: A new role for brain aromatase? J Comp Neurol 423: 549-551, 2000
29. Felson DT, and Cummings SR: Aromatase inhibitors and the syndrome of arthralgias with estrogen deprivation. Arthritis Rheum 52:2594-2598, 2005
30. Toesca A, Pagnotta A, Zumbo A, Sadun R: Estrogen and progesterone receptors in carpal tunnel syndrome. Cell Biol Int 32:75-79, 2008
31. Nishihori T, Choi J, Di Giovanna MP, et al: Carpal tunnel syndrome associated with the use of aromatase inhibitors in breast cancer. Clin Breast Cancer 8:362-365, 2008